Compared with CBF AML, CEBPA, WT1, NPM1 and IDH1/2 cooccurred more frequently in KIT mut/CBF-neg AML with statistically significance (see Supplemental Fig. 2). The gene discussed is IDH1; the disease is acute myeloid leukemia.